Triple-drug therapy safely cuts serious asthma flares
HAMILTON, ON (May 19, 2021) – Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe asthma. A team from McMaster University and The Research Institute of St. Joe’s Hamilton announced their findings…